Jazz Pharmaceuticals plc
JAZZ
$167.10
$0.390.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 251.41M | -718.47M | -92.54M | 191.12M | 215.06M |
| Total Depreciation and Amortization | 178.25M | 174.01M | 164.87M | 168.42M | 165.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.89M | 960.43M | 69.55M | 118.98M | 44.84M |
| Change in Net Operating Assets | 130.85M | -327.12M | 287.90M | -79.93M | -26.38M |
| Cash from Operations | 474.62M | 88.86M | 429.78M | 398.58M | 398.75M |
| Capital Expenditure | -15.18M | -12.97M | -13.88M | -13.29M | -10.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -858.05M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -312.63M | 230.00M | -155.05M | -180.00M | 224.88M |
| Cash from Investing | -327.80M | -641.02M | -168.93M | -193.29M | 214.09M |
| Total Debt Issued | -- | -- | -- | 0.00 | 980.77M |
| Total Debt Repaid | -7.75M | -7.75M | -757.75M | -7.75M | -582.75M |
| Issuance of Common Stock | 733.00K | 10.50M | 11.45M | 9.20M | 17.00K |
| Repurchase of Common Stock | -3.81M | -127.27M | -67.16M | -4.01M | -151.61M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -5.72M | -- |
| Cash from Financing | -10.83M | -124.53M | -813.47M | -8.28M | 246.43M |
| Foreign Exchange rate Adjustments | 203.00K | 4.62M | 1.70M | -2.29M | 3.07M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.19M | -672.07M | -550.92M | 194.73M | 862.33M |